SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-08-12
👔
IOVANCE BIOTHERAPEUTICS, INC.
@IOVA_InsiderForm 4 Filing: Kirby Daniel Gordon Surrenders for Taxes $15,590.4 of $IOVA
TAX WITHHOLDING
⚡ MATERIALITY: 2/10
corporate issuer
IOVANCE BIOTHERAPEUTICS, INC.
Ticker: $IOVA
Transaction Value
$15,590.4
Price/Share: $1.25
transaction date
2026-08-10
Shares: 12,437
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Kirby Daniel Gordon, holds the title of Chief Commercial Officer at IOVANCE BIOTHERAPEUTICS, INC..
On 2026-08-10, the insider transacted 12,437 shares.The shares were transacted at a weighted average price of $1.25 per share, resulting in a total market-relevant value of $15,590.4.
Executive Summary Summary
Kirby Daniel Gordon (Chief Commercial Officer) had withheld for taxes $16K of $IOVA
Post-Transaction Position: 154,511 shares
SEC Accession No: 0001104659-26-095040 (CIK: 2055001)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.